Tenet Healthcare (THC) has been in focus after fourth quarter 2025 results topped revenue and profit expectations, paired with 2026 guidance that points to higher adjusted EBITDA and continued share repurchases.

The latest earnings beat, 2026 guidance and ongoing buybacks have arrived after a strong run, with a 19.8% 3 month share price return and a very large 5 year total shareholder return. This suggests momentum has been building rather than fading.

If Tenet’s update has you looking across healthcare, this is a good moment to scan 25 healthcare AI stocks as another way to uncover potential ideas in the sector.

With Tenet trading at $231.10, a 3 month return of 19.8% and an intrinsic value model implying a large discount, the key question now is whether there is still a buying opportunity or if the market is already pricing in future growth.

Most Popular Narrative: 11.1% Undervalued

Tenet Healthcare’s most followed narrative pegs fair value at $260 versus the last close of $231.10, implying upside based on discounted future earnings and cash flows using a 7.13% discount rate.

The company's ongoing investment and expansion in its United Surgical Partners International (USPI) ambulatory platform, with healthy M&A and de novo pipeline targeting high-acuity, high-margin service lines such as orthopedics, is shifting Tenet’s portfolio toward outpatient care; this shift enhances net margins as USPI delivers EBITDA margins near 38%, materially higher than legacy hospital operations.

Curious what kind of revenue mix, margin profile and future earnings multiple are baked into that $260 figure, and how they tie back to ACA related volume trends and buybacks? The full narrative lays out the exact growth path and profitability assumptions behind that valuation.

Result: Fair Value of $260 (UNDERVALUED)

However, you still need to weigh risks such as policy changes around ACA subsidies and Tenet’s high debt load, which could challenge those bullish valuation assumptions.

Build Your Own Tenet Healthcare Narrative

If you look at the numbers and reach a different view, or simply prefer to test your own assumptions against the data, you can build a tailored narrative for Tenet in just a few minutes with Do it your way.

A great starting point for your Tenet Healthcare research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.

Looking for more investment ideas?

If you stop here, you risk missing other opportunities that fit your style, so take a few minutes to scan targeted lists built from consistent data.

• Target reliable cash generators by checking companies in our 53 high quality undervalued stocks that pair quality fundamentals with prices that may not fully reflect them.
• Strengthen your income stream by reviewing potential high yield candidates in the 13 dividend fortresses that focus on substantial payouts.
• Prioritise resilience by scanning the 85 resilient stocks with low risk scores to spot businesses with characteristics that may suit a more cautious approach.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.